These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12114299)

  • 21. Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome.
    Noureldine MHA; Nour-Eldine W; Khamashta MA; Uthman I
    Semin Arthritis Rheum; 2019 Apr; 48(5):860-866. PubMed ID: 30217394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary antiphospholipid antibody syndrome presenting with encephalopathy, psychosis and seizures.
    Taipa R; Santos E
    Lupus; 2011 Nov; 20(13):1433-5. PubMed ID: 21768180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological manifestations of antiphospholipid syndrome.
    Rodrigues CE; Carvalho JF; Shoenfeld Y
    Eur J Clin Invest; 2010 Apr; 40(4):350-9. PubMed ID: 20192975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid syndrome: a comprehensive review of a complex and multisystemic disease.
    Palomo I; Segovia F; Ortega C; Pierangeli S
    Clin Exp Rheumatol; 2009; 27(4):668-77. PubMed ID: 19772805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperactivity in a mouse model of the antiphospholipid syndrome.
    Katzav A; Pick CG; Korczyn AD; Oest E; Blank M; Shoenfeld Y; Chapman J
    Lupus; 2001; 10(7):496-9. PubMed ID: 11480848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
    Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
    Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome?
    Jara LJ; Medina G; Cruz-Cruz P; Olivares-Rivera J; Duarte-Salazar C; Saavedra MA
    Isr Med Assoc J; 2017 Jun; 19(6):382-386. PubMed ID: 28647939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Non-Criteria' Neurologic Manifestations of Antiphospholipid Syndrome: A Hidden Kingdom to be Discovered.
    Islam MA; Alam F; Kamal MA; Wong KK; Sasongko TH; Gan SH
    CNS Neurol Disord Drug Targets; 2016; 15(10):1253-1265. PubMed ID: 27658514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenic mechanisms of the anti-phospholipid antibodies].
    Núñez-Álvarez CA; Cabiedes J
    Reumatol Clin; 2011; 7(1):72-6. PubMed ID: 21794784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?
    Galli M
    Haemostasis; 2000; 30 Suppl 2():57-62. PubMed ID: 11251342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe neurological and obstetrical complications in a patient with antiphospholipid syndrome].
    Bobrowska-Snarska D; Ostanek L; Nesterowicz B; Brzosko M
    Pol Arch Med Wewn; 2006 May; 115(5):457-62. PubMed ID: 17195361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies.
    Donohoe S; Kingdom JC; Mackie IJ; Burrell S; Quenby S; Jauniaux E; Machin SJ
    Thromb Haemost; 2000 Jul; 84(1):32-8. PubMed ID: 10928466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
    Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
    Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
    Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
    Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obstetric and vascular APS: same autoantibodies but different diseases?
    Meroni PL; Raschi E; Grossi C; Pregnolato F; Trespidi L; Acaia B; Borghi MO
    Lupus; 2012 Jun; 21(7):708-10. PubMed ID: 22635208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer.
    Shoenfeld Y; Nahum A; Korczyn AD; Dano M; Rabinowitz R; Beilin O; Pick CG; Leider-Trejo L; Kalashnikova L; Blank M; Chapman J
    Lupus; 2003; 12(6):436-42. PubMed ID: 12873044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurological Manifestations in Antiphospholipid Syndrome].
    Abe N; Atsumi T
    Brain Nerve; 2021 May; 73(5):526-536. PubMed ID: 34006685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.